This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
a
Advertisement
Articles by a
Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Advertisement
Latest Updated Articles
- Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release
Published: February 2nd 2011 | Updated:
- Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis
Published: January 7th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
3
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
4
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
5
